Previous 10 | Next 10 |
home / stock / lbltf / lbltf news
Lattice Biologics Ltd. ( TSX-V: LBL ) (OTCBB: LBLTF) (“ Lattice Biologics ” or the “ Company ”) announces financial results for Q4 2020 and year end 2020. Highlights of Year Ended September 30, 2020 Sales and Product Offerings ...
Lattice Biologics Ltd. ( TSX-V: LBL ) (OTCBB: LBLTF) (“ Lattice Biologics ” or the “ Company ”) at the request of the Investment Industry Regulatory Organization of Canada (“IIROC”), wishes to confirm that it is not aware of any ...
Lattice Biologics Ltd. ( TSX-V: LBL ) (OTCBB: LBLTF) (“Lattice Biologics” or the “Company”) announces cessation of patient recruitment for its Phase 1 study. The study was designed to evaluate the efficacy and safety of AmnioBoost in patients with acute respira...
Lattice Biologics Ltd. ( TSX-V: LBL ) (OTCBB: LBLTF) (“ Lattice Biologics ” or the “ Company ”) announces financial results for Q3 2020. Highlights of the Three Months Ended June 30, 2020 Sales and Product Offerings Gross profit margin was 29...
Lattice Biologics Ltd. ( TSX-V: LBL ) (OTCBB: LBLTF) (“Lattice Biologics” or the “Company”) has issued common shares and warrants pursuant to a litigation settlement. Pursuant to the litigation settlement Ms. Cheryl Farmer acquired 18,000,000 common shares of t...
Lattice Biologics Ltd. ( TSX-V: LBL ) (OTCBB: LBLTF) (“Lattice Biologics” or the “Company”) is pleased to announce that it has obtained TSX-V approval to issue 16,760,000 common shares of the Company to settle outstanding debt. Can$838,000 in debt held by Guy C...
Lattice Biologics Ltd. ( TSX-V: LBL ) (OTCBB: LBLTF) (“ Lattice Biologics ” or the “ Company ”) announces financial results for Q2 2020 Highlights of the Three and Six Months Ended March 31, 2020 Sales and Product Offerings Gross profit ...
Lattice Biologics Ltd. ( TSX-V: LBL ) (OTCBB: LBLTF) (“Lattice Biologics” or the “Company”) is pleased to announce the addition of Chad Green, RRT, to the clinical development team. Mr. Green is a registered respiratory therapist, and President- elect of the Montan...
Lattice Biologics Ltd. ( TSX-V: LBL ) (OTCBB: LBLTF) (“ Lattice Biologics ” or the “ Company ”) announces that the Company has repriced the strike price of the 3 million stock options originally to be granted to Directors and Employees announced on March 16, 20...
Lattice Biologics Ltd. ( TSX-V: LBL ) (OTCBB: LBLTF) (“Lattice Biologics” or the “Company”) is pleased to announce that it has entered into a definitive agreement (the "Agreement") with Alumina Partners (Ontario) Ltd. (" Alumina ") for a commitment of up to $6,...
News, Short Squeeze, Breakout and More Instantly...
Lattice Biologics Ltd Company Name:
LBLTF Stock Symbol:
OTCMKTS Market:
Late in the trading day on Friday, July, 9, Lattice Biologics Ltd. ( TSX-V: LBL ) (OTCBB: LBLTF) issued an update on the company which has been unable to trade its stock for over a month. The company had originally made biologic products for use in the field of bone regeneration i...
Lattice Biologics Ltd. ( TSX-V: LBL ) (OTCBB: LBLTF) (“ Lattice Biologics ” or the “ Company ”) announces financial results for Q2 2021. Highlights of Six Months Ended March 31, 2021 Sales and Product Offerings ...
Lattice Biologics Ltd. ( TSX-V: LBL ) (OTCBB: LBLTF) (“Lattice” or the “Company”), an emerging leader in psilocybin research and cannabis company, today announced the formation of its Strategic Advisory Board, a group of respected business leaders that wi...